Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertical Licensing
| Формат: | Электронный ресурс Журнал |
|---|---|
| Язык: | английский |
| Опубликовано: |
MarketLine, a Progressive Digital Media business
|
| Online-ссылка: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Схожие документы
IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
Roche-Kosan Case Study: Successful Early Licensing Strategies
Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
Aventis SWOT Analysis
Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio
Sanofi-Aventis SWOT Analysis
Licensing Loyalty
по: McLeod
по: McLeod
License to Play
по: Daliot-Bul
по: Daliot-Bul
License to Wed
по: Richman
по: Richman
Licensing Journal
Failing Families, Failing Science
по: Lincoln
по: Lincoln
Licensed Practical Nurse
Vertical Reefs
по: Wicksten
по: Wicksten
Lipitor Case Study: Lifecycle Management Strategies
Failed Frontiersmen
по: Donahue
по: Donahue
Words Fail
по: Dickinson
по: Dickinson
The Revolution that Failed
по: Fairclough
по: Fairclough
Failed Evidence
по: Harris
по: Harris
Failed Promises
по: Konisky
по: Konisky
IPO Exit Strategies Case Study: Undertaking a Successful IPO Exit Strategy
Staging Harmony
по: Brokaw
по: Brokaw
Staging Asia
по: Kuruppath
по: Kuruppath
Setting the Stage
по: Hays
по: Hays
Subversive Stages
по: Komporaly
по: Komporaly
Staging Revolution
по: Fan
по: Fan
Occupying the Stage
по: Bredeson
по: Bredeson
Staging Family
по: Mullenneaux
по: Mullenneaux
Staging the Amistad
по: Christensen
по: Christensen
On Stage Alone
по: Gitelman
по: Gitelman
Staging Ghana
по: Schauert
по: Schauert
Stage for Action
по: Dail
по: Dail
The Stages of Memory
по: Young
по: Young
Схожие документы
- IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
- Roche-Kosan Case Study: Successful Early Licensing Strategies
- Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
- Aventis SWOT Analysis
- Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio